StockData
AbbVie Inc. logo

AbbVie Inc.

ABBVNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 3, 2026Score 10/3089% above fair value
$288.84−6.05 (-2.05%)

Close on Nov 2, 2026Market cap $510.41BP/E 81.6Yield 2.30%

AbbVie All Other Countries by Year

All Other Countries ($M) ($M)

AbbVie All Other Countries: $5,759M in FY2025, up 5.7% from a year earlier. That is the highest of the 11 years on record here.

Latest, FY2025
5,759
Period ended Dec 31, 2025
Change on a year earlier
+5.7%
5,449 in FY2024
History
11 years
Since FY2015
Sources
9
Documents cited below

Where the FY2025 figure comes from

Source: Form 10-K (filed 2026-02-20) ↗

Reported in Form 10-K Note 16 Segment & Geographic Information.

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedAll Other Countries ($M) ($M)Year on yearSource
FY2025Dec 31, 20255,759+5.7%Form 10-K (filed 2026-02-20) ↗
FY2024Dec 31, 20245,449+8.1%Form 10-K (filed 2026-02-20) ↗
FY2023Dec 31, 20235,042+4.2%Form 10-K (filed 2026-02-20) ↗
FY2022Dec 31, 20224,837+1.6%Form 10-K (filed 2025-02-14) ↗
FY2021Dec 31, 20214,761+19.7%Form 10-K (filed 2024-02-20) ↗
FY2020Dec 31, 20203,977+11.5%Form 10-K (filed 2023-02-17) ↗
FY2019Dec 31, 20193,566-7.7%Form 10-K (filed 2022-02-18) ↗
FY2018Dec 31, 20183,863-5.3%Form 10-K (filed 2021-02-19) ↗
FY2017Dec 31, 20174,080+5.0%Form 10-K (filed 2020-02-21) ↗
FY2016Dec 31, 20163,885-2.9%Form 10-K (filed 2019-02-27) ↗
FY2015Dec 31, 20154,001–Form 10-K (filed 2018-02-16) ↗

Cite this data

StockData. (2026). AbbVie All Other Countries ($M), annual FY2015–FY2025 [Data set]. Compiled from AbbVie SEC filings and investor materials. https://stockdatahq.com/stocks/abbv/kpis/geo-rev-other

See every metric in the AbbVie KPI table. Data updated Oct 26, 2026.